Literature DB >> 17054911

Obestatin does not activate orphan G protein-coupled receptor GPR39.

Erwin Lauwers1, Bart Landuyt, Lutgarde Arckens, Liliane Schoofs, Walter Luyten.   

Abstract

Recently, the ligand of the orphan G protein-coupled receptor GPR39 has been identified as obestatin, a 23-amino acid peptide derived from the ghrelin precursor protein. We used two methods to study the possible activation of GPR39 by obestatin: cAMP measurements based on a luminescent reporter gene and a fluorometric Ca(2+) flux method. The former was similar to that reported in the original publication of Zhang et al. [J.V. Zhang, P.G. Ren, O. Avsian-Kretchmer, C.W. Luo, R. Rauch, C. Klein, Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake, Science 310 (2005) 996-999]. The latter method used promiscuous as well as chimaeric G-proteins commonly used to couple orphan G protein-coupled receptors to the phospholipase C pathway, that leads to intracellular Ca(2+) rise. We could, however, not demonstrate activation of the GPR39 receptor by obestatin via any of these signal transduction pathways. We could activate GPR39 by high concentrations of Zn(2+), demonstrating cell surface expression of a functional receptor that could elicit a Ca(2+) response. The Zn(2+) response was not affected by obestatin. The identity of the native ligand for GPR39 remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17054911     DOI: 10.1016/j.bbrc.2006.09.141

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  54 in total

Review 1.  GPR39: a Zn(2+)-activated G protein-coupled receptor that regulates pancreatic, gastrointestinal and neuronal functions.

Authors:  Petra Popovics; Alan J Stewart
Journal:  Cell Mol Life Sci       Date:  2010-09-02       Impact factor: 9.261

2.  Circulating obestatin levels in normal and Type 2 diabetic subjects.

Authors:  D H St-Pierre; F Settanni; I Olivetti; E Gramaglia; M Tomelini; R Granata; F Prodam; A Benso; E Ghigo; F Broglio
Journal:  J Endocrinol Invest       Date:  2010-05-05       Impact factor: 4.256

3.  Obestatin partially affects ghrelin stimulation of food intake and growth hormone secretion in rodents.

Authors:  Philippe Zizzari; Romaine Longchamps; Jacques Epelbaum; Marie Thérèse Bluet-Pajot
Journal:  Endocrinology       Date:  2007-01-04       Impact factor: 4.736

4.  Intracerebroventricular acute and chronic administration of obestatin minimally affect food intake but not weight gain in the rat.

Authors:  V Sibilia; E Bresciani; N Lattuada; D Rapetti; V Locatelli; V De Luca; F Donà; C Netti; A Torsello; F Guidobono
Journal:  J Endocrinol Invest       Date:  2006-12       Impact factor: 4.256

Review 5.  Central dysregulations in the control of energy homeostasis and endocrine alterations in anorexia and bulimia nervosa.

Authors:  A Torsello; F Brambilla; L Tamiazzo; I Bulgarelli; D Rapetti; E Bresciani; V Locatelli
Journal:  J Endocrinol Invest       Date:  2007-12       Impact factor: 4.256

Review 6.  Orphan GPCR research.

Authors:  S Chung; T Funakoshi; O Civelli
Journal:  Br J Pharmacol       Date:  2007-12-10       Impact factor: 8.739

7.  Influence of short- and long-term treadmill exercises on levels of ghrelin, obestatin and NPY in plasma and brain extraction of obese rats.

Authors:  Jun Wang; Chen Chen; Rui-Yuan Wang
Journal:  Endocrine       Date:  2008-04-04       Impact factor: 3.633

8.  Effect of peripheral obestatin on food intake and gastric emptying in ghrelin-knockout mice.

Authors:  I Depoortere; T Thijs; D Moechars; B De Smet; L Ver Donck; T L Peeters
Journal:  Br J Pharmacol       Date:  2008-01-21       Impact factor: 8.739

9.  Ghrelin receptor activity amplifies hippocampal N-methyl-d-aspartate receptor-mediated postsynaptic currents and increases phosphorylation of the GluN1 subunit at Ser896 and Ser897.

Authors:  Brandon G Muniz; Masako Isokawa
Journal:  Eur J Neurosci       Date:  2015-11-17       Impact factor: 3.386

10.  G protein-coupled receptor 39 deficiency is associated with pancreatic islet dysfunction.

Authors:  Birgitte Holst; Kristoffer L Egerod; Chunyu Jin; Pia Steen Petersen; Mette Viberg Østergaard; Jacob Hald; A M Ejernaes Sprinkel; Joachim Størling; Thomas Mandrup-Poulsen; Jens J Holst; Peter Thams; Cathrine Orskov; Nils Wierup; Frank Sundler; Ole D Madsen; Thue W Schwartz
Journal:  Endocrinology       Date:  2009-02-12       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.